ITIL-168 in Advanced Melanoma
Trial details
- Registry ID
- NCT05050006
- Phase
- Phase 2
Company identity has not yet been verified
Browse linked trials and recorded changes, or follow this company for updates.
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| ITIL-168 in Advanced MelanomaNCT05050006 | Instil Bio | Phase 2 | Terminated | 2023-02-27Actual |